Legal & General Group PLC Athira Pharma, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	BUY	$2.74 - $13.43 $1,323 - $6,486	483 Added 18.79%	3,053 $9,000
Q2 2021 Aug 12, 2021	BUY	$10.24 - $20.87 $12,380 - $25,231	1,209 Added 88.83%	2,570 $26,000
Q4 2020 Feb 12, 2021	BUY	$16.48 - $34.3 $20,814 - $43,320	1,263 Added 1288.78%	1,361 $47,000
Q3 2020 Nov 13, 2020	BUY	$16.02 - $18.46 $1,569 - $1,809	98 New	98 $2,000

16.8M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $18.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.